Navigation Links
Pharsight Uses FDA Disease Model to Support Oncology Drug Development
Date:11/20/2007

y Decisions: Data/models of Diseases, Drugs, Placebo, Baseline, and Dropouts." Additional information can be found at http://www.diahome.org or requested from FDA at pharmacometrics@fda.hhs.gov.

"As outlined in FDA's Critical Path Initiative, model-based drug development offers an important approach to improving drug development knowledge management and decision-making," said Shawn O'Connor, president, chief executive officer, and chairman of Pharsight. "We are pleased that FDA has shared their NSCLC survival model with the public to describe prior knowledge in this area. With our unmatched collective modeling expertise, Pharsight scientists are uniquely positioned to help our clients build, adapt, and extend drug-disease models in their own development programs. Over the past three years, we have supported more than 30 oncology programs and modeling initiatives for industry clients, from pre-clinical to Phase III and covering critical issues in trial design, dose selection, and development strategy. We look forward to collaborating with our client to share feedback with FDA, and to contributing to ongoing industry discussions on opportunities for sharing drug-disease models to support quantitative decision-making in clinical development."

About Pharsight Corporation

Pharsight Corporation develops and markets integrated products and services that enable pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products. Pharsight's goal is to help customers reduce the time, cost and risk of drug development, as well as optimize the post-approval marketing and use of pharmaceutical products.

Pharsight's approach enhances the fundamental element of drug development success: strong decision-making. By adopting the Pharsight approach, customers acquire a new decision-making process with the potential to systematically imp
'/>"/>

SOURCE Pharsight Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
2. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
3. Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
4. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
5. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
6. Baxter and The Alzheimers Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimers Disease
7. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
8. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
9. Public Forum to Discuss Addiction as a Treatable Disease and Highlight National Alcohol and Drug Addiction Recovery Month
10. K-State Researchers Bringing Expertise to Kansas City Symposium on Disease and National Security
11. Genta Initiates First Clinical Trial with New Oral Drug (G4544) to Treat Bone Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , Sep. 02, 2015 ... announced the addition of Jain PharmaBiotech,s new report ... Companies" to their offering. This ... clinical specialty, aimed at improving patient care by ... adjust the dose of drugs for improving outcome. ...
(Date:9/2/2015)... 2015  ArmaGen, Inc., a privately held biotechnology ... severe neurological disorders, announced today that the first ... 1/2a clinical trial of AGT-181 in patients with ... AGT-181 is an investigational enzyme replacement therapy ... most severe form of MPS I, Hurler syndrome, ...
(Date:9/2/2015)... 2015  Boca Raton Regional Hospital,s Richard ... ultra-minimally invasive left atrial appendage ligation for atrial ... Coumadin, Xarelto or Effient. Dr. Cartledge, who is ... one of a select group of surgeons nationally ... incisions in order to seal off the left ...
Breaking Medicine Technology:Global Therapeutic Drug Monitoring Technologies, Markets, and Companies Report 2015 - Updated 2015 Analysis with Forecasts to 2024 2ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 2ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 3ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 4Boca Regional Introduces Ultra-Minimally Invasive Surgical Procedure for Atrial Fibrillation Patients 2Boca Regional Introduces Ultra-Minimally Invasive Surgical Procedure for Atrial Fibrillation Patients 3
... Represent Strongest Support for Coiling Since Groundbreaking 2002 ... ... Calif., Aug. 1 A new study reveals that,coiling, a minimally ... recurrent or first-time bleeding years after,initial treatment in those aneurysms considered ...
... MARLBOROUGH, Mass., Aug. 1 CardioFocus, Inc. announced,today ... for its proprietary,Endoscopic Ablation System. This novel transvenous ... with the,delivery of therapeutic light energy to perform ... The Endoscopic Ablation System has been designed ...
Cached Medicine Technology:New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results 2New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results 3CardioFocus Endoscopic Ablation System Earns CE Mark to Treat Atrial Fibrillation; US Clinical Investigation Underway 2CardioFocus Endoscopic Ablation System Earns CE Mark to Treat Atrial Fibrillation; US Clinical Investigation Underway 3
(Date:9/2/2015)... Jose, CA (PRWEB) , ... September 02, 2015 ... ... for Internet of Things, announces its latest addition to its screen mirroring and ... existing award-winning Splashtop Extended Wireless Display, which operates in local WIFI setting, the ...
(Date:9/2/2015)... ... ... The medical waste management market is expected to reach USD 13.3 billion by 2020 ... waste management market is segmented based on type of waste, services, treatment type, treatment ... growth rate in the medical waste management market, by service, during the forecast period. ...
(Date:9/2/2015)... ... September 02, 2015 , ... A ... partnership has earned international recognition as a premier center for treatment of and ... sudden, catastrophic internal bleeding and stroke. , Cure HHT, previously known as ...
(Date:9/2/2015)... , ... September 02, 2015 , ... ... Center at Children's Healthcare of Atlanta to help support childhood cancer research. ... the upcoming WSB Radio Care-A-Thon , which is the fund-raising event DoMyOwnPestControl.com ...
(Date:9/2/2015)... ... 02, 2015 , ... A third party administrator (TPA) based ... a significant increase in unlawful tactics used by out-of-network (OON) ambulatory surgical centers ... OON ASCs encouraging members to have elective procedures done at their facilities with ...
Breaking Medicine News(10 mins):Health News:Splashtop Launches Wired XDisplay, the Fastest Screen Sharing Solution for Extending and Mirroring Your Computer Screen to Mobile Devices 2Health News:Splashtop Launches Wired XDisplay, the Fastest Screen Sharing Solution for Extending and Mirroring Your Computer Screen to Mobile Devices 3Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 2Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 3Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 4Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 5Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 2Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 4Health News:DoMyOwnPestControl.com Goes Gold for Childhood Cancer Awareness Month 2Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 2Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 3
... Corporation,(Nasdaq: PODD ), the manufacturer and marketer ... Duane DeSisto, Chief Executive,Officer, will participate in the ... to present an overview of the Company,at 1:30 ... at The Westin St.,Francis Hotel in San Francisco., ...
... Officer of Aetna, Inc., LOVELAND, Colo., Jan. ... announced that Ms. Louise McCormick has joined the,company,s ... "We pride ourselves on our commitment to ... high quality, independent Directors,is critical to this effort," ...
... chances of damage to areas that control language , , WEDNESDAY, ... enable surgeons to perform brain surgery with less damage to ... As a bonus, brain researchers may also get a more ... , The new technique, described in the Jan. 3 issue ...
... ANN ARBOR, Mich. One in four Americans in the ... them will get a urinary tract infection from that catheter. ... life-threatening complications. , And with every new case, UTIs ... for 40 percent of infections related to hospitalization. , ...
... Tenn.Obese people are less likely to use their seatbelts ... public health risks associated with this rapidly growing problem. ... psychologist David Schlundt and his colleagues at Meharry Medical ... weight goes up, seatbelt use goes down, Schlundt, associate ...
... cancer in the bulls eye. , Cancer really comes from us, ... scary reality that cancer cells are our own cells gone awry. ... horrific invader. , Tumors and T cells, the cellular arm of ... for many years before the tumor grows, says Dr. He, who ...
Cached Medicine News:Health News:Louise McCormick Joins Heska's Board of Directors 2Health News:Louise McCormick Joins Heska's Board of Directors 3Health News:Scientists Report Refinements to Brain Surgery 2Health News:Catheter chaos: Hospitals lag in preventing common infection 2Health News:Catheter chaos: Hospitals lag in preventing common infection 3Health News:Catheter chaos: Hospitals lag in preventing common infection 4Health News:Obesity linked to decreased seatbelt use 2Health News:New strategies work to put cancer on the firing line 2Health News:New strategies work to put cancer on the firing line 3
... II test is also available with Inverness ... greatly reduces the hands-on time required to ... testing. The Fecal-Quik-Prep device is a unique ... amount of hands-on time required to prepare ...
... Our ELISA products for autoimmune testing feature ... as well as specific reflex tests including ... Sm/RNP, SS-A (Ro), SS-B (La), Scl-70 and ... includes a full line of products for ...
... for autoimmune testing feature single-well ANA screen ... specific reflex tests including dsDNA, and 6 ... SS-B (La), Scl-70 and Jo-1. In addition, ... line of products for Cardiolipins (IgA, IgG, ...
... Our ELISA products for autoimmune testing ... ELISAs, as well as specific reflex tests ... Sm, Sm/RNP, SS-A (Ro), SS-B (La), Scl-70 ... family includes a full line of products ...
Medicine Products: